App watch: new study tests if a phone tool boosts chemo adherence
NCT ID NCT06952790
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 30 times
Summary
This study looks at how cancer patients use a mobile app called EveryDose to track their oral chemotherapy pills. Researchers want to see if the app helps patients take their medicine as prescribed and if they find it easy to use. About 25 adults with cancer who are starting a new oral chemo drug will test the app for 12 weeks. The goal is to learn what works and what doesn't, so better tools can be developed to support patients at home.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Miami
RECRUITINGMiami, Florida, 33136, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.